nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—FGFR2—skull—intracranial aneurysm	0.0331	0.101	CbGeAlD
Regorafenib—TEK—artery—intracranial aneurysm	0.0169	0.0514	CbGeAlD
Regorafenib—FLT1—artery—intracranial aneurysm	0.0163	0.0497	CbGeAlD
Regorafenib—KDR—artery—intracranial aneurysm	0.0138	0.042	CbGeAlD
Regorafenib—NTRK1—midbrain—intracranial aneurysm	0.0126	0.0383	CbGeAlD
Regorafenib—FGFR2—brainstem—intracranial aneurysm	0.00749	0.0228	CbGeAlD
Regorafenib—DDR2—cerebellum—intracranial aneurysm	0.00723	0.022	CbGeAlD
Regorafenib—RAF1—brainstem—intracranial aneurysm	0.0069	0.0211	CbGeAlD
Regorafenib—MAPK11—cerebellum—intracranial aneurysm	0.00685	0.0209	CbGeAlD
Regorafenib—BRAF—midbrain—intracranial aneurysm	0.0066	0.0201	CbGeAlD
Regorafenib—FGFR1—medulla oblongata—intracranial aneurysm	0.00614	0.0187	CbGeAlD
Regorafenib—DDR2—brain—intracranial aneurysm	0.00587	0.0179	CbGeAlD
Regorafenib—FGFR1—midbrain—intracranial aneurysm	0.00561	0.0171	CbGeAlD
Regorafenib—MAPK11—brain—intracranial aneurysm	0.00557	0.017	CbGeAlD
Regorafenib—RET—medulla oblongata—intracranial aneurysm	0.0055	0.0168	CbGeAlD
Regorafenib—KIT—brainstem—intracranial aneurysm	0.0052	0.0159	CbGeAlD
Regorafenib—BRAF—cerebellum—intracranial aneurysm	0.00511	0.0156	CbGeAlD
Regorafenib—RET—midbrain—intracranial aneurysm	0.00502	0.0153	CbGeAlD
Regorafenib—TEK—medulla oblongata—intracranial aneurysm	0.00501	0.0153	CbGeAlD
Regorafenib—EPHX2—cerebellum—intracranial aneurysm	0.00488	0.0149	CbGeAlD
Regorafenib—FLT1—medulla oblongata—intracranial aneurysm	0.00484	0.0148	CbGeAlD
Regorafenib—RAF1—medulla oblongata—intracranial aneurysm	0.00481	0.0147	CbGeAlD
Regorafenib—TEK—midbrain—intracranial aneurysm	0.00458	0.014	CbGeAlD
Regorafenib—ABL1—brainstem—intracranial aneurysm	0.00453	0.0138	CbGeAlD
Regorafenib—FLT1—midbrain—intracranial aneurysm	0.00443	0.0135	CbGeAlD
Regorafenib—RAF1—midbrain—intracranial aneurysm	0.0044	0.0134	CbGeAlD
Regorafenib—FGFR1—cerebellum—intracranial aneurysm	0.00434	0.0132	CbGeAlD
Regorafenib—BRAF—brain—intracranial aneurysm	0.00415	0.0127	CbGeAlD
Regorafenib—KDR—medulla oblongata—intracranial aneurysm	0.00409	0.0125	CbGeAlD
Regorafenib—EPHX2—brain—intracranial aneurysm	0.00397	0.0121	CbGeAlD
Regorafenib—RET—cerebellum—intracranial aneurysm	0.00389	0.0119	CbGeAlD
Regorafenib—KDR—midbrain—intracranial aneurysm	0.00374	0.0114	CbGeAlD
Regorafenib—FGFR2—cerebellum—intracranial aneurysm	0.00369	0.0113	CbGeAlD
Regorafenib—KIT—medulla oblongata—intracranial aneurysm	0.00363	0.0111	CbGeAlD
Regorafenib—FLT4—brain—intracranial aneurysm	0.00358	0.0109	CbGeAlD
Regorafenib—PDGFRB—medulla oblongata—intracranial aneurysm	0.00354	0.0108	CbGeAlD
Regorafenib—TEK—cerebellum—intracranial aneurysm	0.00354	0.0108	CbGeAlD
Regorafenib—FGFR1—brain—intracranial aneurysm	0.00353	0.0108	CbGeAlD
Regorafenib—FLT1—cerebellum—intracranial aneurysm	0.00342	0.0104	CbGeAlD
Regorafenib—RAF1—cerebellum—intracranial aneurysm	0.0034	0.0104	CbGeAlD
Regorafenib—KIT—midbrain—intracranial aneurysm	0.00332	0.0101	CbGeAlD
Regorafenib—PDGFRB—midbrain—intracranial aneurysm	0.00324	0.00988	CbGeAlD
Regorafenib—PDGFRA—cerebellum—intracranial aneurysm	0.00321	0.00978	CbGeAlD
Regorafenib—ABL1—medulla oblongata—intracranial aneurysm	0.00316	0.00963	CbGeAlD
Regorafenib—RET—brain—intracranial aneurysm	0.00316	0.00963	CbGeAlD
Regorafenib—FGFR2—brain—intracranial aneurysm	0.003	0.00915	CbGeAlD
Regorafenib—EPHA2—brain—intracranial aneurysm	0.00295	0.00899	CbGeAlD
Regorafenib—KDR—cerebellum—intracranial aneurysm	0.00289	0.00883	CbGeAlD
Regorafenib—ABL1—midbrain—intracranial aneurysm	0.00289	0.0088	CbGeAlD
Regorafenib—TEK—brain—intracranial aneurysm	0.00288	0.00877	CbGeAlD
Regorafenib—FLT1—brain—intracranial aneurysm	0.00278	0.00848	CbGeAlD
Regorafenib—RAF1—brain—intracranial aneurysm	0.00276	0.00843	CbGeAlD
Regorafenib—PDGFRA—brain—intracranial aneurysm	0.00261	0.00795	CbGeAlD
Regorafenib—KIT—cerebellum—intracranial aneurysm	0.00256	0.00782	CbGeAlD
Regorafenib—PDGFRB—cerebellum—intracranial aneurysm	0.0025	0.00764	CbGeAlD
Regorafenib—KDR—brain—intracranial aneurysm	0.00235	0.00717	CbGeAlD
Regorafenib—ABL1—cerebellum—intracranial aneurysm	0.00223	0.00681	CbGeAlD
Regorafenib—KIT—brain—intracranial aneurysm	0.00208	0.00635	CbGeAlD
Regorafenib—PDGFRB—brain—intracranial aneurysm	0.00203	0.00621	CbGeAlD
Regorafenib—ABCG2—medulla oblongata—intracranial aneurysm	0.00199	0.00607	CbGeAlD
Regorafenib—ABCG2—midbrain—intracranial aneurysm	0.00182	0.00555	CbGeAlD
Regorafenib—ABL1—brain—intracranial aneurysm	0.00181	0.00553	CbGeAlD
Regorafenib—ABCG2—cerebellum—intracranial aneurysm	0.00141	0.00429	CbGeAlD
Regorafenib—CYP2C8—brain—intracranial aneurysm	0.00118	0.00359	CbGeAlD
Regorafenib—ABCG2—brain—intracranial aneurysm	0.00114	0.00349	CbGeAlD
Regorafenib—CYP2B6—brain—intracranial aneurysm	0.00105	0.00322	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—intracranial aneurysm	0.000982	0.00299	CbGeAlD
Regorafenib—ABCB1—midbrain—intracranial aneurysm	0.000897	0.00274	CbGeAlD
Regorafenib—KIT—Innate Immune System—CTSS—intracranial aneurysm	0.000825	0.00123	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CTSS—intracranial aneurysm	0.000806	0.0012	CbGpPWpGaD
Regorafenib—EPHA2—Axon guidance—MMP2—intracranial aneurysm	0.000804	0.0012	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CTSS—intracranial aneurysm	0.000792	0.00118	CbGpPWpGaD
Regorafenib—BRAF—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000787	0.00117	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CTSS—intracranial aneurysm	0.000783	0.00116	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CTSS—intracranial aneurysm	0.000781	0.00116	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STARD13—intracranial aneurysm	0.000775	0.00115	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CTSK—intracranial aneurysm	0.000773	0.00115	CbGpPWpGaD
Regorafenib—RAF1—Disease—SLC25A16—intracranial aneurysm	0.000767	0.00114	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CTSK—intracranial aneurysm	0.000759	0.00113	CbGpPWpGaD
Regorafenib—RAF1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000759	0.00113	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CTSS—intracranial aneurysm	0.000752	0.00112	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CTSS—intracranial aneurysm	0.00075	0.00112	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CTSK—intracranial aneurysm	0.000742	0.0011	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CTSK—intracranial aneurysm	0.000729	0.00108	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CTSK—intracranial aneurysm	0.00072	0.00107	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CTSK—intracranial aneurysm	0.000719	0.00107	CbGpPWpGaD
Regorafenib—RAF1—Signaling by VEGF—NOS3—intracranial aneurysm	0.000716	0.00107	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CTSS—intracranial aneurysm	0.000703	0.00105	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—CTSB—intracranial aneurysm	0.000697	0.00104	CbGpPWpGaD
Regorafenib—ABCB1—cerebellum—intracranial aneurysm	0.000694	0.00212	CbGeAlD
Regorafenib—FGFR1—Adaptive Immune System—CTSK—intracranial aneurysm	0.000692	0.00103	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CTSK—intracranial aneurysm	0.00069	0.00103	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CTSS—intracranial aneurysm	0.000685	0.00102	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CTSS—intracranial aneurysm	0.000675	0.001	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—MMP2—intracranial aneurysm	0.000667	0.000993	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SLC25A16—intracranial aneurysm	0.00066	0.000982	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SLC25A16—intracranial aneurysm	0.00066	0.000982	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000654	0.000973	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CTSK—intracranial aneurysm	0.000647	0.000963	CbGpPWpGaD
Regorafenib—KIT—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000642	0.000955	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CTSB—intracranial aneurysm	0.00064	0.000952	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CTSK—intracranial aneurysm	0.000631	0.000939	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CTSB—intracranial aneurysm	0.000628	0.000935	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CTSS—intracranial aneurysm	0.000627	0.000933	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000624	0.000928	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CTSK—intracranial aneurysm	0.000622	0.000925	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—NOS3—intracranial aneurysm	0.00062	0.000922	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CTSB—intracranial aneurysm	0.000614	0.000914	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NCF1—intracranial aneurysm	0.000612	0.00091	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—NCF1—intracranial aneurysm	0.000611	0.000909	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000609	0.000907	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000608	0.000904	CbGpPWpGaD
Regorafenib—EPHA2—Axon guidance—MMP9—intracranial aneurysm	0.000604	0.000899	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CTSB—intracranial aneurysm	0.000603	0.000898	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CTSS—intracranial aneurysm	0.000602	0.000896	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—NCF1—intracranial aneurysm	0.0006	0.000893	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CTSB—intracranial aneurysm	0.000596	0.000887	CbGpPWpGaD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000595	0.000886	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CTSB—intracranial aneurysm	0.000595	0.000885	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—EDNRA—intracranial aneurysm	0.000578	0.000859	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CTSK—intracranial aneurysm	0.000577	0.000858	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—MMP2—intracranial aneurysm	0.000574	0.000853	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CTSB—intracranial aneurysm	0.000573	0.000852	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CTSB—intracranial aneurysm	0.000571	0.00085	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—NCF1—intracranial aneurysm	0.00057	0.000848	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—NCF1—intracranial aneurysm	0.000568	0.000845	CbGpPWpGaD
Regorafenib—KDR—Axon guidance—MMP2—intracranial aneurysm	0.000566	0.000843	CbGpPWpGaD
Regorafenib—ABCB1—brain—intracranial aneurysm	0.000564	0.00172	CbGeAlD
Regorafenib—ABCG2—Metabolism—SLC25A16—intracranial aneurysm	0.00056	0.000833	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CTSK—intracranial aneurysm	0.000554	0.000824	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000548	0.000815	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000544	0.00081	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CTSB—intracranial aneurysm	0.000536	0.000797	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CTSS—intracranial aneurysm	0.000533	0.000793	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TIMP1—intracranial aneurysm	0.000531	0.00079	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CTSB—intracranial aneurysm	0.000522	0.000777	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000517	0.000769	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CTSB—intracranial aneurysm	0.000515	0.000766	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—NCF1—intracranial aneurysm	0.000512	0.000762	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000501	0.000746	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CTSK—intracranial aneurysm	0.00049	0.00073	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CTSS—intracranial aneurysm	0.000489	0.000728	CbGpPWpGaD
Regorafenib—RAF1—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000488	0.000726	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TIMP1—intracranial aneurysm	0.000486	0.000723	CbGpPWpGaD
Regorafenib—KIT—Immune System—CTSS—intracranial aneurysm	0.00048	0.000715	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CTSB—intracranial aneurysm	0.000478	0.000711	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000461	0.000687	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CTSB—intracranial aneurysm	0.000459	0.000682	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NCF1—intracranial aneurysm	0.000456	0.000679	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—NCF1—intracranial aneurysm	0.000456	0.000679	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CTSS—intracranial aneurysm	0.000456	0.000678	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CTSS—intracranial aneurysm	0.000455	0.000677	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CTSK—intracranial aneurysm	0.00045	0.00067	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—AGER—intracranial aneurysm	0.00045	0.000669	CbGpPWpGaD
Regorafenib—KIT—Immune System—CTSK—intracranial aneurysm	0.000442	0.000658	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ASAH1—intracranial aneurysm	0.000437	0.000651	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ASAH1—intracranial aneurysm	0.000437	0.000651	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—MMP9—intracranial aneurysm	0.000431	0.000641	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000431	0.000641	CbGpPWpGaD
Regorafenib—KDR—Axon guidance—MMP9—intracranial aneurysm	0.000426	0.000633	CbGpPWpGaD
Regorafenib—BRAF—Disease—CST3—intracranial aneurysm	0.000425	0.000632	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000421	0.000626	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CTSK—intracranial aneurysm	0.00042	0.000624	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CTSK—intracranial aneurysm	0.000419	0.000623	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—MMP2—intracranial aneurysm	0.000417	0.00062	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—AGER—intracranial aneurysm	0.000413	0.000614	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC25A16—intracranial aneurysm	0.000411	0.000611	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CTSS—intracranial aneurysm	0.00041	0.00061	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CTSB—intracranial aneurysm	0.000406	0.000604	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—AGER—intracranial aneurysm	0.000406	0.000603	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—MMP2—intracranial aneurysm	0.000404	0.000601	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NCF1—intracranial aneurysm	0.000404	0.000601	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CTSS—intracranial aneurysm	0.000399	0.000594	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CST3—intracranial aneurysm	0.000394	0.000586	CbGpPWpGaD
Regorafenib—KIT—Disease—CST3—intracranial aneurysm	0.000387	0.000575	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—AGER—intracranial aneurysm	0.000385	0.000573	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—AGER—intracranial aneurysm	0.000384	0.000571	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CTSK—intracranial aneurysm	0.000377	0.000561	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CTSB—intracranial aneurysm	0.000373	0.000554	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.000371	0.000552	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NCF1—intracranial aneurysm	0.000371	0.000552	CbGpPWpGaD
Regorafenib—BRAF—Disease—NCF1—intracranial aneurysm	0.000369	0.000549	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CTSK—intracranial aneurysm	0.000367	0.000547	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CST3—intracranial aneurysm	0.000367	0.000546	CbGpPWpGaD
Regorafenib—KIT—Immune System—CTSB—intracranial aneurysm	0.000366	0.000544	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CST3—intracranial aneurysm	0.000366	0.000544	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTSS—intracranial aneurysm	0.000365	0.000543	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—MMP2—intracranial aneurysm	0.000365	0.000543	CbGpPWpGaD
Regorafenib—KIT—Immune System—NCF1—intracranial aneurysm	0.000364	0.000542	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.000348	0.000517	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—MMP2—intracranial aneurysm	0.000348	0.000517	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CTSB—intracranial aneurysm	0.000347	0.000517	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CTSB—intracranial aneurysm	0.000346	0.000515	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—AGER—intracranial aneurysm	0.000346	0.000515	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NCF1—intracranial aneurysm	0.000346	0.000514	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NCF1—intracranial aneurysm	0.000345	0.000513	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NCF1—intracranial aneurysm	0.000342	0.000509	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—AGER—intracranial aneurysm	0.000337	0.000502	CbGpPWpGaD
Regorafenib—KIT—Disease—NCF1—intracranial aneurysm	0.000336	0.0005	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTSK—intracranial aneurysm	0.000336	0.0005	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—MMP2—intracranial aneurysm	0.000334	0.000497	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CST3—intracranial aneurysm	0.00033	0.00049	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000321	0.000478	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NCF1—intracranial aneurysm	0.000319	0.000475	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NCF1—intracranial aneurysm	0.000318	0.000473	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—MMP9—intracranial aneurysm	0.000313	0.000466	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CTSB—intracranial aneurysm	0.000312	0.000464	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NCF1—intracranial aneurysm	0.00031	0.000462	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC25A16—intracranial aneurysm	0.00031	0.000462	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—NOS3—intracranial aneurysm	0.000308	0.000459	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—AGER—intracranial aneurysm	0.000308	0.000459	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CTSB—intracranial aneurysm	0.000304	0.000453	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—MMP9—intracranial aneurysm	0.000304	0.000452	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NCF1—intracranial aneurysm	0.000304	0.000452	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000303	0.000451	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000303	0.000451	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NCF1—intracranial aneurysm	0.000303	0.00045	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—MMP2—intracranial aneurysm	0.000297	0.000442	CbGpPWpGaD
Regorafenib—RAF1—Disease—CST3—intracranial aneurysm	0.000294	0.000437	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EDNRA—intracranial aneurysm	0.000287	0.000427	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NCF1—intracranial aneurysm	0.000287	0.000427	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000286	0.000426	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CCL2—intracranial aneurysm	0.000285	0.000423	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000283	0.000421	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTSB—intracranial aneurysm	0.000278	0.000414	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NCF1—intracranial aneurysm	0.000277	0.000412	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—MMP9—intracranial aneurysm	0.000274	0.000408	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ASAH1—intracranial aneurysm	0.000272	0.000405	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—AGER—intracranial aneurysm	0.000262	0.00039	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—MMP9—intracranial aneurysm	0.000261	0.000389	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NCF1—intracranial aneurysm	0.000261	0.000388	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MMP2—intracranial aneurysm	0.00026	0.000387	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NCF1—intracranial aneurysm	0.000259	0.000385	CbGpPWpGaD
Regorafenib—RAF1—Disease—NCF1—intracranial aneurysm	0.000256	0.00038	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NOS3—intracranial aneurysm	0.000254	0.000377	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—MMP9—intracranial aneurysm	0.000251	0.000373	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EDNRA—intracranial aneurysm	0.000247	0.000367	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EDNRA—intracranial aneurysm	0.000244	0.000363	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AGER—intracranial aneurysm	0.000241	0.000358	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NCF1—intracranial aneurysm	0.00024	0.000357	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—NOS3—intracranial aneurysm	0.000239	0.000356	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MMP2—intracranial aneurysm	0.000238	0.000354	CbGpPWpGaD
Regorafenib—KIT—Immune System—AGER—intracranial aneurysm	0.000236	0.000351	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NCF1—intracranial aneurysm	0.000235	0.00035	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.00023	0.000343	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000226	0.000337	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AGER—intracranial aneurysm	0.000224	0.000334	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AGER—intracranial aneurysm	0.000224	0.000333	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—MMP9—intracranial aneurysm	0.000224	0.000333	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NCF1—intracranial aneurysm	0.000223	0.000332	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NCF1—intracranial aneurysm	0.000223	0.000332	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EDNRA—intracranial aneurysm	0.000222	0.000331	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—NOS3—intracranial aneurysm	0.000219	0.000326	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CCL2—intracranial aneurysm	0.000212	0.000316	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000211	0.000314	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EDNRA—intracranial aneurysm	0.00021	0.000313	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ASAH1—intracranial aneurysm	0.000206	0.000306	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MMP9—intracranial aneurysm	0.000204	0.000303	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AGER—intracranial aneurysm	0.000201	0.0003	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NCF1—intracranial aneurysm	0.000201	0.000299	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000201	0.000298	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AGER—intracranial aneurysm	0.000196	0.000292	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MMP9—intracranial aneurysm	0.000196	0.000291	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EDNRA—intracranial aneurysm	0.00019	0.000282	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NOS3—intracranial aneurysm	0.000189	0.000282	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000187	0.000279	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000187	0.000278	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AGER—intracranial aneurysm	0.00018	0.000267	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MMP9—intracranial aneurysm	0.000179	0.000266	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NCF1—intracranial aneurysm	0.000179	0.000266	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000169	0.000251	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS3—intracranial aneurysm	0.000153	0.000228	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MMP9—intracranial aneurysm	0.000152	0.000226	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000149	0.000222	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS3—intracranial aneurysm	0.000142	0.000211	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCL2—intracranial aneurysm	0.000141	0.00021	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000141	0.00021	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS3—intracranial aneurysm	0.000139	0.000207	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NOS3—intracranial aneurysm	0.000133	0.000198	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS3—intracranial aneurysm	0.000132	0.000197	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS3—intracranial aneurysm	0.000132	0.000196	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NOS3—intracranial aneurysm	0.000126	0.000187	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000124	0.000184	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCL2—intracranial aneurysm	0.000121	0.000181	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCL2—intracranial aneurysm	0.00012	0.000179	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS3—intracranial aneurysm	0.000119	0.000177	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL2—intracranial aneurysm	0.000112	0.000166	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL2—intracranial aneurysm	0.00011	0.000163	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOS3—intracranial aneurysm	0.000108	0.000161	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOS3—intracranial aneurysm	0.000107	0.00016	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—intracranial aneurysm	0.000107	0.000159	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS3—intracranial aneurysm	0.000106	0.000158	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000104	0.000155	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL2—intracranial aneurysm	0.000104	0.000154	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—intracranial aneurysm	0.000101	0.00015	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOS3—intracranial aneurysm	9.94e-05	0.000148	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOS3—intracranial aneurysm	9.76e-05	0.000145	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—intracranial aneurysm	9.34e-05	0.000139	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOS3—intracranial aneurysm	9.27e-05	0.000138	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOS3—intracranial aneurysm	9.24e-05	0.000138	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NOS3—intracranial aneurysm	9.12e-05	0.000136	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NOS3—intracranial aneurysm	9.12e-05	0.000136	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—intracranial aneurysm	8.69e-05	0.000129	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—intracranial aneurysm	8.61e-05	0.000128	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOS3—intracranial aneurysm	8.33e-05	0.000124	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—intracranial aneurysm	8.33e-05	0.000124	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—intracranial aneurysm	7.98e-05	0.000119	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—intracranial aneurysm	7.83e-05	0.000117	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NOS3—intracranial aneurysm	7.74e-05	0.000115	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—intracranial aneurysm	7.43e-05	0.000111	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—intracranial aneurysm	7.42e-05	0.00011	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—intracranial aneurysm	7.41e-05	0.00011	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—intracranial aneurysm	6.68e-05	9.94e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—intracranial aneurysm	5.95e-05	8.86e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—intracranial aneurysm	5.67e-05	8.44e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—intracranial aneurysm	4.8e-05	7.15e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—intracranial aneurysm	4.29e-05	6.38e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—intracranial aneurysm	4.19e-05	6.23e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—intracranial aneurysm	3.91e-05	5.82e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.58e-05	3.84e-05	CbGpPWpGaD
